Tech Company Financing Transactions
ImmunityBio Funding Round
ImmunityBio, operating out of San Diego, scored $75 million in investment from Oberland Capital.
Transaction Overview
Company Name
Announced On
3/31/2026
Transaction Type
Debt
Amount
$75,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3530 John Hopkins Court
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
ImmunityBio, Inc. is a biotechnology company focused on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient's immune system and deliver durable protection against cancer and infectious diseases. Our approach harnesses both the adaptive and innate immune systems with the goal of restoring immune function and generating lasting immunological memory in patients. At the core of our strategy is the Cancer BioShield� platform, which is designed to stimulate critical lymphocytes, including natural killer (NK) cells, cytotoxic T cells, and memory T cells via our proprietary IL-15 receptor superagonist, ANKTIVA® (nogapendekin alfa inbakicept).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Patrick Soon-Shiong
Chief Executive Officer
Rich Adcock
Chief Financial Officer
David Sachs
Chief Marketing Officer
Sarah Singleton
Chief Medical Officer
Sandeep Reddy
Chief Medical Officer
Leonard Sender
Chief Technical Officer
Enrique Diloné
Vice President
Matthew Hilman
VP - Human Resources
Emily Arison
VP - Product Management
Elizabeth Gabitzsch
VP - Product Management
Manju Saxena
VP - Regulatory Affairs
Bruce Brown
VP - Regulatory Affairs
Charles Garlisi
VP - Regulatory Affairs
Barry Simon
Browse more venture capital transactions:
Prev: 3/31/2026: The Better Money Company venture capital transaction
Next: 3/31/2026: Variance venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC transactions on this site come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs